Germanys Pharmaceutical Market Ranks as the Worlds Third Largest, Valued at US$40.0 Billion and a Per Capita Expenditure of US$484

Research and Markets (http://www.researchandmarkets.com/reports/c10110) has announced the addition of Germany Pharmaceutical Country Intelligence Report to their offering

(PRWEB) November 27, 2004 -- Despite economic problems and need for reform in many areas, Germany continues to be one of the worlds strongest healthcare markets. Germanys pharmaceutical market ranks as the worlds third largest, valued at US$40.0 billion and a per capita expenditure of US$484. Germanys pharmaceutical output is currently the fifth largest in the world and exports totalling US$16.9 billion in 2001 made it the largest exporter.

Whatever your needs, whether you are monitoring developments in national markets, identifying new opportunities, assessing product areas, or using the data as an integral part of your market planning, WPM's country reports are invaluable. Sections are included on the organisation and administration of health services, healthcare expenditure, hospital and outpatient services, medical personnel and healthcare development. Issues relevant to the pharmaceutical market environment are outlined, including regulation, registration, patent protection and distribution. The market section includes data on domestic production and international trade.

1.Introduction
2.Background
3.Population
4.Health Status
5.Health Expenditure
6.Organisation & Administration
7.Hospital Services

For more information visit http://www.researchandmarkets.com/reports/c10110

Laura Wood
Senior Manager
Research and Markets
press@researchandmarkets.com
Fax: +353 1 4100 980

###